ADC process and analytical development at World ADC London 2027
Mar 8–11, 2027 London, UK ~700 attendees Website
17 organizations at World ADC London 2027 present work in process & analytical development: 15 technology and service providers and 2 drug developers. Between them they bring 6 presentations to the program. Most represented: AstraZeneca (3 on the program), Pierre Fabre (2 on the program). 16 of them have their own page in this guide. As of Oct 8, 2026.
Format
Top represented
Showing 1–17 of 17 organizations
| Organization | World ADC London 2027 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global pharmaceutical company whose ADCs include trastuzumab deruxtecan and datopotamab deruxtecan, co-developed with Daiichi Sankyo. | Talk Talk Aseptic Manufacturing of Antibody-Drug Conjugates – From Process Development to Validation Manufacturing & supply chain Talk Wed Mar 10 3:30pm A Scalable Lysine Bioconjugation Platform: Reducing Development Burden as Clinical Demand Scales Process & analytical developmentManufacturing & supply chain Also |
Pierre Fabre Castres, France | |
French pharmaceutical and dermo-cosmetics group developing oncology medicines, including antibody-drug conjugates. | Workshop Thu Mar 11 1:00pm Manufacturing Bispecifics, Dual Payloads & Novel Formats (DACs, AOD, POCs) at Scale Manufacturing & supply chain Also |
Lonza Basel, Switzerland | ◆Senior Partner |
Swiss CDMO that has supported more than 100 ADC programs, covering antibodies, payload-linkers, conjugation and fill-finish, plus its GlycoConnect conjugation technology. | Talk Tue Mar 9 5:30pm Lonza’s GlycoConnect® Technology for Best-in-Class ADCs: Emerging Clinical Insights ADC discoveryClinical development |
◆Lead Partner | |
CRDMO dedicated to ADCs and other bioconjugates, covering antibody intermediates, payloads and linkers, and conjugated drug substance and drug product. | Talk Tue Mar 9 9:00am WuXiDARx™ Conjugation Technology & Proprietary Payload-Linker Platform: A Powerful Alliance for Next-Generation Dual Payload ADC Development ADC discoveryManufacturing & supply chain |
◇Program Partner | |
CDMO and CRO for ADCs, antibody-oligonucleotide and radioconjugates and other complex biologics, from discovery through commercial supply, with US and UK sites. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
◇Program Partner | |
Biologics CDMO unit of Asymchem covering antibody, ADC and nucleic acid programs, with linker-payload, antibody and conjugation development, manufacturing and quality control. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
◇Exhibition Partner | |
Contract testing lab focused on protein characterization and analytical services for biologics and biosimilars, with labs in Jersey, the US and Europe. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Cytiva Marlborough, MA | ◇Program Partner |
Supplier of bioprocessing equipment, chromatography resins, filters and single-use systems for biologics development and manufacturing, now combined with Pall Life Sciences. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
FyoniBio Berlin, Germany | ◇Exhibition Partner |
Service provider supporting biologics development with drug characterization, bioanalytical and clinical laboratory services. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Genovis Lund, Sweden | ◇Program Partner |
Swedish supplier of enzymes for biologics analysis and of GlyCLICK glycan-based site-specific conjugation, with a custom conjugation service. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Intertek London, UK | ◇Program Partner |
Testing and assurance group whose pharmaceutical labs provide analytical testing, characterization and bioanalysis for antibodies, ADCs and bispecifics. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
MabPlex Yantai, China | ◇Program Partner |
Chinese CRO and CDMO providing development and GMP manufacturing of therapeutic antibodies and ADCs. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Piramal Pharma Solutions Mumbai, India | ◆Senior Partner |
CDMO with sites in North America, Europe and Asia, offering highly potent API manufacture, antibody-drug conjugation and sterile fill-finish. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
ProJect Pharmaceutics Martinsried, Germany | ◇Exhibition Partner |
German contract lab developing liquid and freeze-dried formulations and lyophilization processes for antibodies, ADCs and other injectable biologics. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Quality Assistance Donstiennes, Belgium | ◇Exhibition Partner |
Contract research organization providing analytical development, characterization, batch release and stability testing for biologics and other medicines. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Simtra BioPharma Solutions Parsippany, NJ | ◇Program Partner |
Sterile injectables CDMO with sites in Indiana and Germany, offering formulation and lyophilization development and adding ADC conjugation capacity in Halle. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Sterling Pharma Solutions Cramlington, UK | ◇Program Partner |
UK-based CDMO for complex chemistry, running an ADC conjugation site in the UK and high-potency payload-linker manufacturing in Wisconsin. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Instantly find 20 buyers in process & analytical development
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World ADC London 2027 by
Track
- ADC discovery 29
- Preclinical & translational 9
- Clinical development 15
- Process & analytical development 17
- Manufacturing & supply chain 31
Everyone
Not affiliated with or endorsed by World ADC or its organizers. Submit a correction